FDA Schedules Pre-License Inspection of Remestemcel-L
Biologics License Application (BLA) Resubmission for Pediatric Acute Graft-Versus-Host Disease (SR-aGVHD) Currently Being Reviewed PDUFA Goal Date...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from First Allogeneic. Real-time updates on events, politics, business and more.